Davis Polk & Wardwell advised the representative of the initial purchasers on the offering. Vishay Intertechnology, Inc. (NYSE: VSH) announced it has completed its offering of $750 million aggregate...
Vishay Intertechnology’s $750 Million Convertible Senior Notes Offering
Coherus BioSciences’ $57.5 Million Follow-On Offering
Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering. Coherus BioSciences, Inc. (“Coherus”, Nasdaq:...
Mirion Technologies’ $85.6 Million Secondary Offering
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
Mirion Technologies’ $150 Million Direct Offering of Common Stock
Davis Polk advised Mirion Technologies on the offering. Mirion Technologies, Inc. announced a registered direct offering of 17,142,857 shares of its Class A common stock at...
RxSight’s $50 Million Common Shares Offering
Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering. RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000...
RAPT Therapeutics’ $75 Million Common Stock Offering
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
Denali Therapeutics’ $316 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
EDAP TMS’s $23 Million Follow-on Offering
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
SVB Financial’s $2.25 Billion Offerings of Notes and Preferred Stock
Davis Polk advised the sole book-running manager and representative of the several underwriters for the offerings. SVB Financial Group executed the offerings of $650 million aggregate...
SVB Financial Group’s $1.25 Billion Stock Offering
Davis Polk advised the sole underwriter, Goldman Sachs & Co. LLC, in the offering. SVB Financial Group. completed a $1.25 billion public offering of common stock. The common...
IDEAYA Biosciences’ $92 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
RAPT Therapeutics’ $143.7 Million Equity Offering
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...